2024 AACR Presentation:

Early Detection of Renal Cell Carcinoma

What We Do

We offer a discovery service to academia, government and industry through the Serimmune universal serology platform that utilizes bacterial display peptide library technology and next generation sequencing to broadly profile antibody repertoires and identify antigens and epitopes associated with many diseases - all in a single assay.


How We Do It

Serimmune’s Serum Epitope Repertoire Analysis (SERA) technology platform applies bacterial display peptide libraries, next-generation sequencing, machine learning and custom bioinformatics to reveal the many diverse antigens stimulating immunity. Through this, we gain a broad view of an individual’s environmental exposures and the unique immune responses to these exposures in disease and health.


Why We Do It

Serimmune was founded on the belief that the information coded in the individual’s functional antibody repertoire is key to understanding human disease. To fulfill this vision, we created a technology for building and interpreting a dynamic map of human immunity which continually evolves to map interactions between functional antibody repertoire and human disease. Linkages between antibody response to pathogens have been shown in oncology, autoimmune, infectious, neurodegenerative, and other complex diseases.

About Us



Target Discovery

Serimmune Biomarker Discovery Service

Learn about Serimmune’s SERA platform which combines large biological libraries, NGS, and custom bioinformatics to unlock the Circulating Antibody Repertoire to achieve hypothesis free serology.

Neutralizing Epitopes

Biomarkers of Response


From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain where science, government and manufacturers all come together to create groundbreaking progress.

Join us at Booth 630!


World Vaccine Congress

April 1st-4th

Washington, D.C.

AACR Annual Meeting

April 5th-10th

San Diego, CA

Serimmune Presentation

April 7, 2024, 1:30 PM - 5:00 PM

Workshops on Recent Issues in Bioanalysis hosts 1000 professionals representing pharma/biotech companies, CROs, and multiple regulatory agencies to discuss current topics of interest.



May 6th-10th

San Antonio, TX

Let's Talk Science

    Areas of Interest (check all that apply):

    Academic and Government Collaborators